Showing results (101-110 of 127) with videos related to
Sort By:
Pageof 13
Seminars in Thrombosis and Hemostasis|February 24, 2015
Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preferenceShabnam Zolfaghari, Job Harenberg, Lutz Frölich, et al.The Journal of Biological Chemistry|January 14, 2005
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splittingAnnamaria Naggi, Benito Casu, Marta Perez, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Orthogonal analytical approaches to detect potential contaminants in heparinMarco Guerrini, Zhenqing Zhang, Zachary Shriver, et al.Clinical Pharmacokinetics|February 12, 2025
Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of ObesityDanilo Menichelli, Arianna Pannunzio, Erminia Baldacci, et al.Journal of Pharmaceutical and Biomedical Analysis|October 30, 2015
Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparinsAnnamaria Naggi, Cristina Gardini, Giacomo Pedrinola, et al.Thrombosis and Haemostasis|July 31, 2003
Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosisHanno Riess, Klaus Koppenhagen, Alexander Tolle, et al.Thrombosis and Haemostasis|July 5, 2022
Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy StudyAnne E Merrelaar, Magdalena S Bögl, Nina Buchtele, et al.Stroke|November 25, 2005
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT TrialHans-Christoph Diener, Erich B Ringelstein, Rüdiger von Kummer, et al.Thrombosis and Haemostasis|January 28, 2022
DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in CirculationSandra Margetić, Ivana Ćelap, Arijana Lovrenčić Huzjan, et al.Seminars in Thrombosis and Hemostasis|February 16, 2015
The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulationPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.Pageof 13